Human Fatty Acid Binding Protein (HFABP) antibody and antigen (hapten, BSA/OVA conjugated)

Diagnostic anti-Human Fatty Acid Binding Protein (HFABP) antibodies (anti-Human Fatty Acid Binding Protein, anti-HFABP) and diagnostic hapten-carrier conjugates BSA-Human Fatty Acid Binding Protein (HFABP), OVA-Human Fatty Acid Binding Protein (HFABP), KLH-Human Fatty Acid Binding Protein (HFABP) antigens for Cardiovascular disease HFABP detection in ELISA test, competitive ELISA, Lateral flow immunoassay (LFIA), CLIA, TINIA and POCT.

Target products collectionGo to Neurodegenerative diseases diagnostics products collection >>


Product information

Catalog No. Description US $ Price (per mg)
GMP-SMT-HFABP-Ag01 BSA-Human Fatty Acid Binding Protein (HFABP) 756
GMP-SMT-HFABP-Ag02 OVA-Human Fatty Acid Binding Protein (HFABP) 756
GMP-SMT-HFABP-Ab01 Anti-human Human Fatty Acid Binding Protein (HFABP) mouse monoclonal antibody (mAb) 1953
GMP-SMT-HFABP-Ab02 Anti-human Human Fatty Acid Binding Protein (HFABP) human monoclonal antibody (mAb) 1953

Size: 1mg | 10mg | 100mg



Product Description

Cat No. of Products GMP-SMT-HFABP-Ag01
Product Name BSA-Human Fatty Acid Binding Protein (HFABP)
Target/Biomarker Human Fatty Acid Binding Protein (HFABP)
Alias of Target/Biomarker FABP11, H-FABP, M-FABP, MDGI, O-FABP
Expression platform Synthetic
Isotypes NA
Bioactivity validation Human Fatty Acid Binding Protein (HFABP) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in HFABP level test of Cardiovascular disease (metabolic syndrome, atherosclerosis, insulin resistance and low-grade inflammation) and related syndrome evaluation.
Tag NA
Products description Competitive immunoassay-validated hapten-carrier conjugates BSA-Human Fatty Acid Binding Protein (HFABP) / OVA-Human Fatty Acid Binding Protein (HFABP) is Synthetic.
Purity Purity: ≥95% (SDS-PAGE)
Application Competitive immunoassay validation (Competitive ELISA), ELISA, Lateral flow immunoassay (LFIA),colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA) and Immunonephelometry.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Cat No. of Products GMP-SMT-HFABP-Ag02
Product Name OVA-Human Fatty Acid Binding Protein (HFABP)
Target/Biomarker Human Fatty Acid Binding Protein (HFABP)
Alias of Target/Biomarker FABP11, H-FABP, M-FABP, MDGI, O-FABP
Expression platform Synthetic
Isotypes NA
Bioactivity validation Human Fatty Acid Binding Protein (HFABP) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in HFABP level test of Cardiovascular disease (metabolic syndrome, atherosclerosis, insulin resistance and low-grade inflammation) and related syndrome evaluation.
Tag NA
Products description Competitive immunoassay-validated hapten-carrier conjugates BSA-Human Fatty Acid Binding Protein (HFABP) / OVA-Human Fatty Acid Binding Protein (HFABP) is Synthetic.
Purity Purity: ≥95% (SDS-PAGE)
Application Competitive immunoassay validation (Competitive ELISA), ELISA, Lateral flow immunoassay (LFIA),colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA) and Immunonephelometry.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Cat No. of Products GMP-SMT-HFABP-Ab01
Product Name Anti-human Human Fatty Acid Binding Protein (HFABP) mouse monoclonal antibody (mAb)
Target/Biomarker Human Fatty Acid Binding Protein (HFABP)
Alias of Target/Biomarker FABP11, H-FABP, M-FABP, MDGI, O-FABP
Expression platform Hybridoma
Isotypes Mouse IgG
Bioactivity validation Human Fatty Acid Binding Protein (HFABP) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in HFABP level test of Cardiovascular disease (metabolic syndrome, atherosclerosis, insulin resistance and low-grade inflammation) and related syndrome evaluation.
Tag mFc
Products description Competitive immunoassay-validated hapten-carrier conjugates BSA-Human Fatty Acid Binding Protein (HFABP) / OVA-Human Fatty Acid Binding Protein (HFABP) is Synthetic.
Purity Purity: ≥95% (SDS-PAGE)
Application Competitive immunoassay validation (Competitive ELISA),Lateral flow immunoassay (LFIA),colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA) and Immunonephelometry.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Cat No. of Products GMP-SMT-HFABP-Ab02
Product Name Anti-human Human Fatty Acid Binding Protein (HFABP) human monoclonal antibody (mAb)
Target/Biomarker Human Fatty Acid Binding Protein (HFABP)
Alias of Target/Biomarker FABP11, H-FABP, M-FABP, MDGI, O-FABP
Expression platform Hybridoma
Isotypes Mouse IgG
Bioactivity validation Human Fatty Acid Binding Protein (HFABP) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in HFABP level test of Cardiovascular disease (metabolic syndrome, atherosclerosis, insulin resistance and low-grade inflammation) and related syndrome evaluation.
Tag mFc
Products description Competitive immunoassay-validated hapten-carrier conjugates BSA-Human Fatty Acid Binding Protein (HFABP) / OVA-Human Fatty Acid Binding Protein (HFABP) is Synthetic.
Purity Purity: ≥95% (SDS-PAGE)
Application Competitive immunoassay validation (Competitive ELISA),Lateral flow immunoassay (LFIA),colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA) and Immunonephelometry.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Validation Data


    Click to get more Data / Case study about the product.



    Target/Biomarker information

    The fatty acid binding proteins (FABPs) are a family of transport proteins for fatty acids and other lipophilic substances such as eicosanoids and retinoids. These proteins are thought to facilitate the transfer of fatty acids between extracellular and intracellular membranes. FABP4 has been associated with several components of metabolic syndrome, atherosclerosis, insulin resistance and low-grade inflammation, and thus, it has been proposed as a cardiometabolic predictor for cardiovascular disease.



    About GDU


    GDU

    GDU helps global diagnostic partners in high quality of raw material discovery, development, and application. GDU believes in Protein&antibody Innovation for more reliable diagnostic solutions.

    Comments


    No comments yet.

    Leave a comment